Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Canopy Growth

SNDL Inc.

Tilray Brands

Cannabis stocks are on the move Tuesday after the Florida Supreme Court approved the ability to add recreational marijuana use to the state's November ballot. This measure will have residents of Florida voting for or against a new amendment that would allow the use of the drug.

Cannabis Stocks Light Up As Florida Adds Weed to November Ballots

Cronos Group

Cannabis stocks often rally on news of any renewed hopes of legalization passing. Many cannabis producers aren't in great financial shape, however.

This Is the Biggest Mistake I See Cannabis Investors Making Over and Over Again

Various themes and sectors garnered buzz and attention as the first quarter drew to a close. However, one industry that has been in a lull for a significant period reignited the imagination and hope of longstanding investors after it finished the first quarter in style.

Green Gold Rush: Here's What's Driving Cannabis Stocks Higher

Cannabis stocks are on the move Monday as investors react to the news that recreational marijuana is now legal in Germany. These new laws do come with some restrictions worth pointing out.

Cannabis Stocks Alert: Recreational Marijuana Just Became Legal in Germany

Few banks will work with cannabis upstarts—but some lawmakers hope to change that this year.

The Big Problem for Marijuana Companies? What to Do With All That Cash

NASDAQ | TSX: ACB The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis Market in Germany EDMONTON, AB , April 1, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – a Canadian based leading global medical cannabis company, applauds the German government's final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act. This change presents long overdue reform in favour of a more accessible medical cannabis market and commitment to patients.

Aurora Cannabis Commends Germany's Landmark Legalization Achievement

Curaleaf Holdings, Inc.

What Cannabis Reform In Germany Means For North American Marijuana Companies

Cannabis stocks are climbing ahead of the German legalization date this Monday, April 1. Indeed, many of the biggest marijuana companies have soared as the country's long-awaited weed decriminalization process comes full circle.

Cannabis Stocks Heat Up Again Ahead of German Rollout

The stock shot up more than 50% on last week's news that Germany will legalize marijuana. Aurora Cannabis shares are retreating Monday as investors book profits and resume worrying about the company's cash burn.

Why Aurora Cannabis Stock Dropped 12% Today

The coming legalization of marijuana in Germany should give a lift to pot stocks like Canopy Growth (NYSE: CGC ), Tilray (NASDAQ: TLRY ), Cronos (NASDAQ: CRON ), SNDL (NASDAQ: SNDL ) and Aurora Cannabis (NASDAQ: ACB ). So far, however, investors are facing a bad trip.

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

Cannabis stocks are surging, helped by positive regulatory steps in the United States. Tilray Brands (NASDAQ: TLRY) stock jumped to $2.4 in the pre-market, its highest level since January 9th of this year.

Tilray and Aurora Cannabis stocks are flying but it's risky to buy

AdvisorShares Pure US Cannabis ETF

Canopy Growth led a weed stock rally early Friday after Germany legalized cannabis. New laws go into effect on April 1.

Canopy Growth, Weed Stocks Rocket After Germany Legalizes Cannabis

Cannabis stocks cooled off Thursday but held onto big gains from the past week on the heels of positive comments from the Biden administration on reclassifying cannabis from a Schedule I controlled substance under federal law.

Cannabis stocks fall but hold onto big gains from the week on brighter federal reform prospects

Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market                                                                                            NASDAQ | TSX: ACB EDMONTON, AB , March 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company has received Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia.

Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance

Cannabis stocks surged Monday after Vice President Kamala Harris called on the Drug Enforcement Administration (DEA) to reschedule marijuana “as quickly as possible.” Cannabis is currently a Schedule 1 narcotic, the same classification as heroin, a point Harris called “absurd” and “patently unfair.

Why Are Cannabis Stocks TLRY, ACB, CGC, SNDL Up Today?

Cannabis stocks moved higher after US Vice President Kamala Harris on Friday urged the Drug Enforcement Administration (DEA) to reschedule marijuana as a lower-risk drug “as quickly as possible.” Harris, at a White House meeting with individuals who have received marijuana pardons from the Biden administration, said that it was “absurd” and “patently unfair” that marijuana remains in the same drug category as heroin and is considered more dangerous than fentanyl.

Cannabis stocks rally as VP Harris calls on DEA to reschedule marijuana ‘as quickly as possible'

It is a good Monday for Cannabis stocks. Canopy Growth (CGC), Curaleaf (CURLF),  and Aurora Cannabis (ACB) stock prices surged by more than 10% in the pre-market session.

Aurora Cannabis, Canopy Growth, Curaleaf stocks spiked: here's why

Neptune Wellness Solutions Inc.

OrganiGram Holdings Inc.

More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.

Top Marijuana Stocks For Trading Today 2024

AngioDynamics

APA Corporation

BioNTech SE

Franco-Nevada C

Gilead Sciences

Xcel Energy

Ordinarily, you'll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound.

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound

NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients EDMONTON, AB , March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.

Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia

NASDAQ | TSX: ACB EDMONTON, AB , Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayment, Aurora's remaining debt1 of $47.9 million relates to Bevo Farms Ltd.

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

NASDAQ | TSX: ACB Partnership will empower UK patients with valuable information and guidance critical to a successful cannabis experience   EDMONTON, AB , Feb. 28, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK. Designed to support UK patients on their journey of well-being, the Script Assist platform provides access to high quality medication through their portal.

Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis

Aurora Cannabis completes reverse share split to maintain NASDAQ listing requirements. Positive developments include five quarters of positive adjusted EBITDA, debt repayment, and guidance for positive cash flow. Focus on international medical cannabis and plant propagation business contribute to growth potential and positive cash flow.

Aurora Cannabis: Barely Surviving Or Soon To Be Thriving?

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at Jefferies believe.  They have a ‘Buy' rating on Organigram, which they said remains a top Canadian cannabis pick, writing in a note to clients that Organigram's first quarter 2024 earnings showed progress on every metric.

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts

People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.

News for Aurora Cannabis Stock (ACB)